BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32875459)

  • 21. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
    Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.
    Xu XL; Zheng WH; Zhu SM; Zhao A; Mao WM
    PLoS One; 2015; 10(7):e0133076. PubMed ID: 26177369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy.
    Chen G; Wang Z; Liu XY; Liu FY
    World J Surg; 2007 May; 31(5):1107-14. PubMed ID: 17426905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of tumor-resident memory T cells in metastatic lymph nodes of esophageal squamous cell carcinoma.
    Natsuki S; Tanaka H; Nishiyama M; Mori T; Deguchi S; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K
    Cancer Sci; 2023 May; 114(5):1846-1858. PubMed ID: 36748311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of pathologically assessing extranodal extension in the thoracic field on the prognosis of esophageal squamous cell carcinoma.
    Okada N; Daiko H; Kanamori J; Sato A; Horikiri Y; Sato T; Fujiwara H; Tomioka T; Fujita T; Kojima T; Fujii S
    Surgery; 2019 Jun; 165(6):1203-1210. PubMed ID: 30850155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and strategy of common hepatic artery lymph node dissection in thoracolaparoscopic esophagectomy for thoracic esophageal squamous cell cancer.
    Han ZY; Kang MQ; Lin JB; Chen SC; Chen S; Yu SB
    Medicine (Baltimore); 2018 Dec; 97(51):e13587. PubMed ID: 30572462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.
    Sun ZG; Wang Z; Liu XY; Liu FY
    World J Surg; 2011 Jan; 35(1):70-7. PubMed ID: 21046381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus.
    Kanda M; Koike M; Shimizu D; Tanaka C; Hattori N; Hayashi M; Yamada S; Omae K; Kodera Y
    Ann Surg Oncol; 2020 Sep; 27(9):3195-3205. PubMed ID: 32246314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of patients who develop cervical lymph node recurrence following curative resection for thoracic esophageal cancer.
    Yano M; Takachi K; Doki Y; Miyashiro I; Kishi K; Noura S; Eguchi H; Yamada T; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Matsunaga T; Imaoka S
    Dis Esophagus; 2006; 19(2):73-7. PubMed ID: 16643173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus.
    Miyata H; Sugimura K; Motoori M; Omori T; Yamamoto K; Yanagimoto Y; Shinno N; Yasui M; Takahashi H; Wada H; Ohue M; Yano M
    Surgery; 2019 Dec; 166(6):1033-1040. PubMed ID: 31493901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma.
    Chen J; Cai W; Lin Y; Chen Y; Zheng Q; Pan J; Chen C
    PLoS One; 2017; 12(10):e0185424. PubMed ID: 29016614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes and benefits for staging of surgical lymph node mapping after esophagectomy.
    Lagarde SM; Phillips AW; Navidi M; Disep B; Griffin SM
    Dis Esophagus; 2017 Dec; 30(12):1-7. PubMed ID: 28881884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of the number of negative lymph nodes in esophageal cancer patients after transthoracic resection.
    Hsu PK; Huang CS; Wang BY; Wu YC; Chou TY; Hsu WH
    Ann Thorac Surg; 2013 Sep; 96(3):995-1001. PubMed ID: 23866797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the causes of failure after radical surgery in patients with
    Shen WB; Gao HM; Zhu SC; Li YM; Li SG; Xu JR
    World J Surg Oncol; 2017 Oct; 15(1):192. PubMed ID: 29070049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome of transthoracic esophagectomy with thoracic duct resection: Number of dissected lymph node and distribution of lymph node metastasis around the thoracic duct.
    Matsuda S; Takeuchi H; Kawakubo H; Shimada A; Fukuda K; Nakamura R; Takahashi T; Wada N; Kameyama K; Kitagawa Y
    Medicine (Baltimore); 2016 Jun; 95(24):e3839. PubMed ID: 27310961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upper mediastinal lymph node dissection based on mesenteric excision in esophageal cancer surgery: confirmation by near-infrared image-guided lymphatic mapping and the impact on locoregional control.
    Hosogi H; Yagi D; Sakaguchi M; Akagawa S; Tokoro Y; Kanaya S
    Esophagus; 2021 Apr; 18(2):219-227. PubMed ID: 33074447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer.
    Kawamoto T; Nihei K; Sasai K; Karasawa K
    Esophagus; 2018 Oct; 15(4):256-262. PubMed ID: 30225742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
    Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
    Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.